Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

Clinical trial NCT02533375 · COMPLETED

Trial details

NCT number: NCT02533375
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Pustular Psoriasis (GPP)Adalimumab Japanese

Start date: 2015-09-28
Primary completion: 2016-09-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.